Prostate cancer is the most common cancer in men worldwide. Thanks to scientific breakthroughs, there are more ways than ever to treat it — especially when it’s caught early. One ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

The global intraoperative radiation therapy systems market is poised for significant growth, with projections indicating a substantial increase in value over the next decade. According to recent ...

A Texas man with terminal prostate cancer is spending the remainder of his time helping others all over the country ...

It gives me a great sense of pride and delight to write this. We all change as we traverse the pathway of our lives. I have ...

The associate medical director of University Hospitals of Northamptonshire (UHN), Chandran Tanabalan, said: "Focal therapy ...

these researchers report 5-year outcomes for 901 men who underwent prostatectomy and 286 who received external beam radiotherapy, but who were otherwise similar clinically and demographically.

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and ...

Researchers in Canada are developing a low-cost orthovoltage radiotherapy system for use in low-resource and geographically ...